• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗霍尔木兹甘省2020 - 2021年新冠肺炎住院患者住院时间和死亡率的预测因素:一项回顾性队列研究。

Predictors of hospital length of stay and mortality among COVID-19 inpatients during 2020-2021 in Hormozgan Province of Iran: A retrospective cohort study.

作者信息

Mastaneh Zahra, Mouseli Ali, Mohseni Shokrollah, Dadipoor Sara

机构信息

Department of Health Information Management and Technology, School of Allied Medical Sciences, Infectious and Tropical Diseases Research Center Hormozgan University of Medical Sciences Bandar Abbas Iran.

Department of Public Health, School of Health, Social Determinants in Health Promotion Research Center, Hormozgan Health Institute Hormozgan University of Medical Sciences Bandar Abbas Iran.

出版信息

Health Sci Rep. 2023 Jun 14;6(6):e1329. doi: 10.1002/hsr2.1329. eCollection 2023 Jun.

DOI:10.1002/hsr2.1329
PMID:37324249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10265171/
Abstract

BACKGROUND AND AIMS

About one-fifth of patients with COVID-19 need to be hospitalized. Predicting factors affecting the hospital length of stay (LOS) can be effective in prioritizing patients, planning for services, and preventing the increase in LOS and death of patients. The present study aimed to identify the factors that predict LOS and mortality in COVID-19 patients in a retrospective cohort study.

METHODS

A total of 27,859 patients were admitted to 22 hospitals from February 20, 2020 to June 21, 2021. The data collected from 12,454 patients were screened according to the inclusion and exclusion criteria. The data were captured from the MCMC (Medical Care Monitoring Center) database. The study tracked patients until their hospital discharge or death. Hospital LOS and mortality were assessed as the study outcomes.

RESULTS

As the results revealed, 50.8% of patients were male and 49.2% were female. The mean hospital LOS of the discharged patients was 4.94. Yet, 9.1% of the patients ( = 1133) died. Among the predictors of mortality and long hospital LOS were the age above 60, admission to the ICU, coughs, respiratory distress, intubation, oxygen level less than 93%, cigarette and drug abuse, and a history of chronic diseases. Masculinity, gastrointestinal symptoms, and cancer were the effective variables in mortality, and positive CT was a factor significantly affecting the hospital LOS.

CONCLUSION

Paying special attention to high-risk patients and modifiable risk factors such as heart disease, liver disease, and other chronic diseases can diminish the complications and mortality rate of COVID-19. Providing training, especially for those who care for patients experiencing respiratory distress such as nurses and operating room personnel can improve the qualifications and skills of medical staff. Also, ensuring the availability of sufficient supply of medical equipment is strongly recommended.

摘要

背景与目的

约五分之一的新冠病毒疾病(COVID-19)患者需要住院治疗。预测影响住院时长(LOS)的因素有助于对患者进行优先排序、规划服务,并防止患者住院时长增加和死亡。本研究旨在通过一项回顾性队列研究,确定预测COVID-19患者住院时长和死亡率的因素。

方法

2020年2月20日至2021年6月21日期间,共有27859名患者入住22家医院。根据纳入和排除标准,对从12454名患者收集的数据进行筛选。数据来自马尔代夫医疗监测中心(MCMC)数据库。该研究对患者进行跟踪,直至其出院或死亡。将住院时长和死亡率作为研究结果进行评估。

结果

结果显示,50.8%的患者为男性,49.2%为女性。出院患者的平均住院时长为4.94天。然而,9.1%的患者(n = 1133)死亡。年龄在60岁以上、入住重症监护病房(ICU)、咳嗽、呼吸窘迫、插管、血氧水平低于93%、吸烟和药物滥用以及有慢性病病史是死亡率和住院时间延长的预测因素。男性、胃肠道症状和癌症是影响死亡率的有效变量,而CT阳性是显著影响住院时长的一个因素。

结论

特别关注高危患者以及心脏病、肝病和其他慢性病等可改变的风险因素,可以降低COVID-19的并发症和死亡率。提供培训,特别是对护士和手术室工作人员等照顾呼吸窘迫患者的人员进行培训,可以提高医务人员的资质和技能。此外,强烈建议确保有足够的医疗设备供应。

相似文献

1
Predictors of hospital length of stay and mortality among COVID-19 inpatients during 2020-2021 in Hormozgan Province of Iran: A retrospective cohort study.伊朗霍尔木兹甘省2020 - 2021年新冠肺炎住院患者住院时间和死亡率的预测因素:一项回顾性队列研究。
Health Sci Rep. 2023 Jun 14;6(6):e1329. doi: 10.1002/hsr2.1329. eCollection 2023 Jun.
2
Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.伊朗克尔曼沙阿省 27256 例住院 COVID-19 患者的人口统计学、临床特征和结局:一项回顾性一年队列研究。
BMC Infect Dis. 2022 Mar 31;22(1):319. doi: 10.1186/s12879-022-07312-7.
3
Predictive value of multiple variable models including nutritional risk score (NRS 2002) on mortality and length of stay of patients with covid-19 infections. The INCOVO study.多变量模型(包括营养风险评分(NRS 2002))对 COVID-19 感染患者死亡率和住院时间的预测价值。INCOVO 研究。
Clin Nutr ESPEN. 2023 Jun;55:357-363. doi: 10.1016/j.clnesp.2023.04.001. Epub 2023 Apr 11.
4
Factors Influencing the Length of Hospital Stay Among Pediatric COVID-19 Patients at Queen Rania Al Abdullah Hospital for Children: A Cross-Sectional Study.影响阿卜杜拉王后儿童医院儿童新冠患者住院时间的因素:一项横断面研究
Cureus. 2023 Feb 14;15(2):e35000. doi: 10.7759/cureus.35000. eCollection 2023 Feb.
5
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.与美国 COVID-19 患者住院死亡率相关的风险因素。
JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.
6
Length of hospital stay and risk of intensive care admission and in-hospital death among COVID-19 patients in Norway: a register-based cohort study comparing patients fully vaccinated with an mRNA vaccine to unvaccinated patients.挪威 COVID-19 患者住院时间与入住重症监护病房和院内死亡风险的关系:一项基于登记的队列研究,比较了完全接种 mRNA 疫苗的患者与未接种疫苗的患者。
Clin Microbiol Infect. 2022 Jun;28(6):871-878. doi: 10.1016/j.cmi.2022.01.033. Epub 2022 Feb 25.
7
8
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
9
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
10
Metabolic Syndrome and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19.COVID-19 住院患者中的代谢综合征与急性呼吸窘迫综合征。
JAMA Netw Open. 2021 Dec 1;4(12):e2140568. doi: 10.1001/jamanetworkopen.2021.40568.

引用本文的文献

1
Classification and Regression Trees analysis identifies patients at high risk for kidney function decline following hospitalization.分类与回归树分析可识别出住院后肾功能下降风险较高的患者。
PLoS One. 2025 Jan 31;20(1):e0317558. doi: 10.1371/journal.pone.0317558. eCollection 2025.

本文引用的文献

1
COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes.COVID-19 与合并症:风险、协同作用和临床结局。
Front Immunol. 2022 May 27;13:890517. doi: 10.3389/fimmu.2022.890517. eCollection 2022.
2
Factors associated with prolonged length of hospital stay among COVID-19 cases admitted to the largest treatment center in Eastern Ethiopia.埃塞俄比亚东部最大治疗中心收治的新冠肺炎病例中与住院时间延长相关的因素。
SAGE Open Med. 2022 Jan 19;10:20503121211070366. doi: 10.1177/20503121211070366. eCollection 2022.
3
Determinants of COVID-19-Related Length of Hospital Stays and Long COVID in Ghana: A Cross-Sectional Analysis.
加纳与新冠病毒相关的住院时长和新冠后症状的决定因素:一项横断面分析
Int J Environ Res Public Health. 2022 Jan 4;19(1):527. doi: 10.3390/ijerph19010527.
4
Predictors of Mortality Among Hospitalized COVID-19 Patients at a Tertiary Care Hospital in Ethiopia.埃塞俄比亚一家三级护理医院中住院的新冠肺炎患者的死亡预测因素
Infect Drug Resist. 2021 Dec 14;14:5363-5373. doi: 10.2147/IDR.S337699. eCollection 2021.
5
Mortality predictors of hospitalized patients with COVID-19: Retrospective cohort study from Nur-Sultan, Kazakhstan.COVID-19 住院患者的死亡预测因素:来自哈萨克斯坦努尔苏丹的回顾性队列研究。
PLoS One. 2021 Dec 22;16(12):e0261272. doi: 10.1371/journal.pone.0261272. eCollection 2021.
6
SARS-CoV-2, COVID-19 and the Ageing Immune System.SARS-CoV-2、COVID-19 和衰老的免疫系统。
Nat Aging. 2021 Sep;1(9):769-782. doi: 10.1038/s43587-021-00114-7. Epub 2021 Sep 14.
7
Early Determinants of Length of Hospital Stay: A Case Control Survival Analysis among COVID-19 Patients admitted in a Tertiary Healthcare Facility of East India.住院时间长短的早期决定因素:印度东部一家三级医疗机构收治的 COVID-19 患者的病例对照生存分析。
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211054281. doi: 10.1177/21501327211054281.
8
Effects of adding L-arginine orally to standard therapy in patients with COVID-19: A randomized, double-blind, placebo-controlled, parallel-group trial. Results of the first interim analysis.新型冠状病毒肺炎患者在标准治疗基础上加用口服L-精氨酸的效果:一项随机、双盲、安慰剂对照、平行组试验。首次中期分析结果
EClinicalMedicine. 2021 Oct;40:101125. doi: 10.1016/j.eclinm.2021.101125. Epub 2021 Sep 9.
9
Outcome evaluation of COVID-19 infected patients by disease symptoms: a cross-sectional study in Ilam Province, Iran.伊朗伊拉姆省基于疾病症状对 COVID-19 感染患者的结局评估:一项横断面研究。
BMC Infect Dis. 2021 Sep 3;21(1):903. doi: 10.1186/s12879-021-06613-7.
10
COVID-19-related hospital cost-outcome analysis: The impact of clinical and demographic factors.COVID-19 相关的医院成本-结果分析:临床和人口统计学因素的影响。
Braz J Infect Dis. 2021 Jul-Aug;25(4):101609. doi: 10.1016/j.bjid.2021.101609. Epub 2021 Aug 19.